Squarepoint’s Global Cord Blood Corporation CO Stock Holding History

Squarepoint’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-14,133	Closed	-$52K	–	3891
2020 Q4	$52K	Buy	+14,133	New	+$54.2K	﹤0.01%	2803
2020 Q3	–	Sell	-20,814	Closed	-$65K	–	3025
2020 Q2	$65K	Sell	20,814 -7,924	-28%	-$23K	﹤0.01%	2074
2020 Q1	$91K	Sell	28,738 -2,010	-7%	-$8.79K	﹤0.01%	1661
2019 Q4	$154K	Buy	+30,748	New	+$147K	﹤0.01%	2275
2019 Q3	–	Sell	-10,918	Closed	-$63K	–	2881
2019 Q2	$63K	Buy	+10,918	New	+$72K	﹤0.01%	2269

Other funds holding CO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Squarepoint's CO Position: Q1 2021 in Review

Squarepoint sold out of Global Cord Blood Corporation (CO) in Q1 2021, closing a stake of 14,133 shares — an estimated $52K sold.

Squarepoint first reported a position in CO in Q2 2019 and held it in 5 quarters. The position peaked at $154K in Q4 2019. 32 funds tracked by Wall St. Rank hold CO as of Q1 2021.

Squarepoint reported no remaining Global Cord Blood Corporation position as of Q1 2021 after selling out during the quarter.
Squarepoint sold 14,133 Global Cord Blood Corporation shares in Q1 2021, an estimated $52K.
Squarepoint first reported a position in Global Cord Blood Corporation in Q2 2019 and held it in 5 quarters.
Squarepoint's Global Cord Blood Corporation position peaked at $154K in Q4 2019.
32 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.